Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E39.50 EPS (ttm)2.71 Insider Own12.10% Shs Outstand1.01B Perf Week-6.50%
Market Cap108.43B Forward P/E16.28 EPS next Y6.58 Insider Trans-1.00% Shs Float968.86M Perf Month-5.56%
Income2.75B PEG4.49 EPS next Q1.45 Inst Own83.30% Short Float1.19% Perf Quarter-10.73%
Sales23.95B P/S4.53 EPS this Y102.80% Inst Trans0.15% Short Ratio2.65 Perf Half Y-8.54%
Book/sh2.53 P/B42.33 EPS next Y16.92% ROA14.80% Target Price124.33 Perf Year20.23%
Cash/sh2.11 P/C50.73 EPS next 5Y8.80% ROE67.70% 52W Range88.17 - 132.13 Perf YTD-7.46%
Dividend2.58 P/FCF58.30 EPS past 5Y-5.30% ROI14.70% 52W High-18.59% Beta0.19
Dividend %2.41% Quick Ratio0.80 Sales past 5Y1.20% Gross Margin75.00% 52W Low22.00% ATR2.41
Employees38680 Current Ratio1.10 Sales Q/Q2.60% Oper. Margin12.50% RSI (14)36.60 Volatility2.40% 1.81%
OptionableYes Debt/Eq6.44 EPS Q/Q-48.70% Profit Margin26.10% Rel Volume0.60 Prev Close107.09
ShortableYes LT Debt/Eq5.49 EarningsJul 30 BMO Payout36.90% Avg Volume4.34M Price107.57
Recom2.50 SMA20-4.24% SMA50-5.90% SMA200-7.74% Volume1,602,162 Change0.44%
May-28-19Initiated Goldman Buy
Apr-24-19Upgrade Edward Jones Hold → Buy
Apr-11-19Downgrade Guggenheim Buy → Neutral
Mar-12-19Initiated JP Morgan Overweight $140
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-18-19 11:18AM  NuCana Initiates Dosing in Phase I Study for Solid Tumors Zacks
10:26AM  AC Immune Initiates Phase I Study for Alzheimer's Disease Zacks
Jul-17-19 07:00AM  AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer, an Investigational Treatment for Alzheimers Disease GlobeNewswire
Jul-16-19 09:51AM  Here's a Prescription for Eli Lilly Stock: Don't Swallow Yet TheStreet.com
09:36AM  Alkermes to Include Bipolar I Disorder in ALKS 3831 NDA Zacks
07:31AM  Jim Cramer Weighs In On Marvell, General Motors And More Benzinga
Jul-13-19 06:45AM  Lilly Presents New Findings on Stigma Faced by People with Migraine Based on Interim Results from the OVERCOME Observational Study PR Newswire
Jul-12-19 11:35AM  Drug Pricing Woes Linger on Repealing Drug Rebate Proposal Zacks
10:23AM  Health Care stocks help lead Wall Street rally Yahoo Finance Video
10:19AM  Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug Benzinga
08:00AM  Lilly's OVERCOME Observational Study Reveals Inconsistent and Sub-Optimal Treatment Landscape for Migraine PR Newswire
06:45AM  AHS 2019: Post-Hoc Analyses of Phase 3 Pivotal Studies of Emgality® (galcanezumab-gnlm) Show Improvements in Daily Functioning and Reductions in Disability in Patients with Chronic and Episodic Migraine PR Newswire
Jul-11-19 04:22PM  Drug distributors surge, drug makers tumble after Trump administration reverses stance on rebates Yahoo Finance
03:00PM  4 Drug Stocks Getting Smashed InvestorPlace
12:58PM  4 Medical Stocks to Consider After Federal Judge Blocks Trump Proposal Zacks
10:58AM  The Zacks Analyst Blog Highlights: Bank of America, Eli Lilly, Boston Scientific, Schwab and Advanced Micro Devices Zacks
09:13AM  UPDATE 1-Eli Lilly's bio-medicines head to leave next month Reuters
08:32AM  Eli Lilly's bio-medicines head to leave next month Reuters
08:15AM  Lilly Announces Changes in Senior Leadership PR Newswire
06:45AM  New England Journal of Medicine Publishes Positive Phase 3 Data for Emgality® (galcanezumab-gnlm) in Episodic Cluster Headache PR Newswire
06:07AM  Stocks - Health Insurers Drive Dow to New Record at Opening Investing.com
Jul-10-19 03:13PM  Top Stock Reports for Bank of America, Eli Lilly & Boston Scientific Zacks
02:15PM  Lilly Announces Upcoming Presentation of New Data Indicating Rise in Opioid Use for Migraine Treatment PR Newswire
01:16PM  The 10 Biggest Healthcare Stocks Motley Fool
11:24AM  Court Ruling Topples Trump Order, No Price Display in TV Ads Zacks
Jul-09-19 04:15PM  Lilly Confirms Date and Conference Call for Second-Quarter 2019 Financial Results Announcement PR Newswire
11:15AM  Merck, Amgen, and Eli Lilly Get a Drug Pricing Win in Court Barrons.com
10:11AM  Which Pharmaceutical Stocks Are Outperforming All Other Stocks? Investor's Business Daily
09:05AM  3 Big Stock Charts for Tuesday: Eli Lilly, SYSCO and Interpublic Group InvestorPlace
Jul-08-19 06:36PM  UPDATE 4-U.S. judge strikes down Trump administration rule requiring drug prices in TV ads Reuters
06:25PM  U.S. judge halts rule requiring drug prices in TV ads Reuters
Jul-03-19 10:23AM  Incyte Out-Licenses INCMGA0012 Rights in China to Zai Lab Zacks
10:13AM  Will the Pharma Space Witness More Mega-Merger Deals in 2H? Zacks
09:15AM  Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio Zacks
06:04AM  Is Eli Lilly and Company (NYSE:LLY) A Good Dividend Stock? Simply Wall St.
Jul-02-19 04:56PM  Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis Zacks
12:46PM  13 Blue-Chip Stocks With Risks You Need to Watch Kiplinger
09:54AM  Gilead to Submit NDA for Inflammation Drug Filgotinib in '19 Zacks
Jul-01-19 07:00AM  Market Morning: OPEC Cuts, Trump & Xi Ceasefire, Apple Goes to China, Deutsche Bank Hiring Market Exclusive
Jun-29-19 09:57PM  How Adobe Inc and Other Hedge Fund Favorites Performed in Q2 Insider Monkey
02:33PM  UPDATE 1-American caravan arrives in Canadian "birthplace of insulin" for cheaper medicine Reuters
12:58PM  American caravan arrives in Canadian "birthplace of insulin" for cheaper medicine Reuters
Jun-28-19 09:44AM  Pharma Stock Roundup: ABBV to Buy AGN, BMY to Sell CELG's Otezla to Close Merger Zacks
Jun-27-19 10:54AM  Lilly's Study on Higher Doses of Trulicity Meets Endpoint Zacks
Jun-26-19 10:22AM  Lilly's Heart Drug Snags Fast Track Designation; Type 2 Diabetes Drug Found Effective At Higher Doses Benzinga
07:19AM  The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart Benzinga
06:45AM  Lilly's AWARD-11 trial studying higher investigational doses of Trulicity® (dulaglutide) demonstrated superiority in A1C reduction in people with type 2 diabetes PR Newswire
06:00AM  U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure PR Newswire
Jun-25-19 04:19PM  Axsome Initiates Phase III Study on Depression Candidate Zacks
11:39AM  Allergan acquisition is a major bailout for shareholders, according to analysts MarketWatch
11:02AM  The 10 Biggest Biotech Stocks Motley Fool
09:34AM  Allergan Up As Analyst Statement Sparks Business Split Rumors Zacks
Jun-24-19 04:23PM  Why These Innovative Biotech ETFs Soaring Zacks
10:27AM  Allergan's Botox Wins FDA Nod for Upper Limb Spasticity in Kids Zacks
Jun-19-19 12:05PM  Lilly Declares Third-Quarter 2019 Dividend PR Newswire
Jun-18-19 09:51AM  Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio Zacks
09:18AM  Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients Zacks
07:09AM  Shares of cancer-therapy companies skyrocket after Pfizer acquisition news MarketWatch
Jun-17-19 09:35AM  Pfizer Expands in Cancer With $10.6 Billion Deal for Array Bloomberg
09:30AM  Pfizer's $11 Billion Cancer-Drug Deal Takes Pricey Path to Growth Bloomberg
09:15AM  Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice Zacks
Jun-14-19 03:14PM  U.S. drugmakers file lawsuit against rule requiring drug prices in TV ads Reuters
08:42AM  Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod Zacks
06:45AM  Lilly Presents Positive Results for Taltz® (ixekizumab) vs. Humira® (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis at the European Congress of Rheumatology PR Newswire
05:19AM  Drugmakers sue to stop rule requiring prices in TV ads Financial Times
Jun-13-19 04:12PM  Amgen, Biogen, Gilead and Novo Nordisk have very high capacity for M&A, says Moodys MarketWatch
10:26AM  NuCana's Biliary Tract Cancer Candidate Gets Orphan Drug Tag Zacks
10:14AM  Eli Lilly Broke Below the 200-Day Average to Change the Narrative to Bearish TheStreet.com
08:24AM  Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study Zacks
Jun-12-19 07:01PM  Jim Cramer: A Tale of Two Stocks TheStreet.com
06:38PM  Galapagos Ends Enrollment in Osteoarthritis Study Before Time Zacks
08:28AM  Boost Your Portfolio's Health With These 3 Big Drug Stocks Zacks
Jun-11-19 11:19AM  The Zacks Analyst Blog Highlights: Oracle, Eli Lilly, Mondelez, Walgreens and Southwest Zacks
09:03AM  Lilly Announces Tradjenta Cardiovascular Outcome Study Data Zacks
08:53AM  Merck (MRK) to Buy Private Biotech Tilos for Up to $773M Zacks
07:34AM  The Daily Biotech Pulse: Lilly Reports Positive Long-Term Efficacy Data For Psoriasis Drug, Provention Bio Offering Benzinga
03:00AM  Lilly to Present 5-Year Sustained Efficacy and Safety Results for Taltz® (ixekizumab) in Patients with Plaque Psoriasis at the World Congress of Dermatology PR Newswire
Jun-10-19 09:30PM  Detailed findings from CAROLINA® outcome trial support long-term cardiovascular safety profile of Tradjenta® PR Newswire
02:47PM  Top Analyst Reports for Oracle, Eli Lilly & Mondelez Zacks
01:00PM  New analysis shows cardiorenal risk reductions of Jardiance® are consistent in adults with type 2 diabetes, cardiovascular disease and kidney disease without overt proteinuria PR Newswire
09:57AM  The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AstraZeneca Zacks
09:13AM  Eli Lilly stock down 2.4% after Trulicity trial misses investors' expectations MarketWatch
09:06AM  Eli Lilly Stock Is Falling and Novo Nordisk Is Rising on Diabetes-Drug Results Barrons.com
08:40AM  Lilly (LLY) Presents Data From Diabetes Studies at ADA Meet Zacks
08:29AM  Thor Industries and Eli Lilly Offer a Tale of Two Stocks TheStreet.com
Jun-09-19 07:30PM  Trulicity® (dulaglutide) significantly reduced major cardiovascular events for broad range of people with type 2 diabetes PR Newswire
11:30AM  Lilly's ultra rapid lispro provided similar A1C reductions compared to Humalog® (insulin lispro), with superior post-meal blood glucose reductions PR Newswire
Jun-08-19 08:30PM  Lilly's tirzepatide demonstrates benefits in data presented at the American Diabetes Association's® 79 Scientific Sessions® PR Newswire
Jun-07-19 01:53PM  Heres What Hedge Funds Think About Eli Lilly and Company (LLY) Insider Monkey
10:21AM  Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache Zacks
Jun-06-19 03:26PM  Incyte Begins Phase III Study for Treatment of Duct Cancer Zacks
09:22AM  Lilly's Emgality Gets FDA Approval for Cluster Headache Zacks
06:45AM  Lilly to Present New Data and Commitment to Patient-Centered Solutions at the Annual European Congress of Rheumatology PR Newswire
Jun-05-19 01:25PM  Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction TheStreet.com
12:53PM  Eli Lilly gets FDA approval for cluster headache medication Yahoo Finance Video
12:21PM  How Merck reached new ground in the fight against cancer Yahoo Finance Video
07:30AM  The Daily Biotech Pulse: Curtains Down On ASCO, Rewalk Flies, Eli Lilly's Migraine Drug Approved For Cluster Headache Benzinga
06:45AM  Lilly to Showcase Scientific Innovation within Dermatology Portfolio at 24th World Congress of Dermatology PR Newswire
06:39AM  Eli Lilly's Emgality gets FDA approval for episodic cluster headaches MarketWatch
Jun-04-19 09:01PM  FDA Approves Emgality® (galcanezumab-gnlm) as the First and Only Medication for the Treatment of Episodic Cluster Headache that Reduces the Frequency of Attacks PR Newswire
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as migraine prevention. In addition, it offers immunology products for the treatment of rheumatoid arthritis and plaque psoriasis; oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia, and acute coronary syndrome. Further, the company provides animal health products, such as cattle feed additives; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and enteric diseases in swine and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; Dicerna Pharmaceuticals; AC Immune SA; and Avidity Biosciences, Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smiley Joshua LSVP and CFOJul 15Buy108.4718520,06730,595Jul 15 03:46 PM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39404,036Jul 08 03:57 PM
Smiley Joshua LSVP and CFOJun 05Buy118.0342650,28130,410Jun 05 02:15 PM
Harrington Michael JSenior VP and General CounselJun 03Sale116.7216,0001,867,520110,300Jun 04 01:57 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 03Sale117.147,577887,5700May 07 02:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:04 PM
Zulueta Alfonso GSVP & President, Lilly Int'lApr 12Sale124.6510,0001,246,50057,806Apr 16 02:48 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMApr 12Sale125.154,735592,58522,085Apr 16 02:36 PM
Shah Aarti S.SVP & CIOApr 05Sale125.851,800226,53018,425Apr 08 02:54 PM
LILLY ENDOWMENT INC10% OwnerMar 26Sale131.41205,00026,938,688116,810,304Mar 27 02:57 PM
Zakrowski Donald AChief Accounting OfficerMar 22Sale128.501,000128,5004,595Mar 22 03:16 PM
Fry Stephen FSVP, HR & DiversityMar 12Sale123.1614,8471,828,557109,663Mar 13 12:47 PM
LILLY ENDOWMENT INC10% OwnerMar 01Sale128.43210,00026,971,215117,015,304Mar 04 02:13 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale127.011,000127,0105,595Mar 05 03:51 PM
LILLY ENDOWMENT INC10% OwnerFeb 28Sale126.73200,00025,345,017117,225,304Mar 01 01:25 PM
LILLY ENDOWMENT INC10% OwnerFeb 22Sale124.19195,00024,217,635117,425,304Feb 25 04:06 PM
LILLY ENDOWMENT INC10% OwnerFeb 19Sale122.48205,00025,108,513117,620,304Feb 20 01:35 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048082Feb 20 03:52 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 15Sale121.0025,0003,025,000132,962Feb 20 03:37 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.003,221054,175Feb 06 08:10 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.009,722050,946Feb 05 07:09 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0012,2220131,708Feb 05 07:04 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0012,7780102,548Feb 05 06:59 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.008,8890109,100Feb 05 06:55 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0012,2220136,756Feb 05 06:49 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.003,333020,901Feb 05 06:43 PM
LILLY ENDOWMENT INC10% OwnerJan 17Sale118.33136,57716,161,281117,825,304Jan 18 01:14 PM
LILLY ENDOWMENT INC10% OwnerJan 16Sale117.871,657195,315117,961,881Jan 17 01:15 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale117.7451,7666,095,136117,963,538Jan 16 02:36 PM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 10Sale112.9225,0002,822,95950,954Dec 12 03:15 PM
LILLY ENDOWMENT INC10% OwnerDec 04Sale119.0015,5001,844,536118,015,304Dec 06 03:43 PM
White Anne E.SVP & Pres-Lilly OncologyDec 02Option Exercise0.007,500017,103Dec 04 03:14 PM
LILLY ENDOWMENT INC10% OwnerNov 29Sale117.42185,00021,722,429118,030,804Nov 30 11:52 AM
LILLY ENDOWMENT INC10% OwnerNov 28Sale115.57190,00021,957,939118,215,804Nov 29 10:55 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.31195,00022,485,572118,405,804Nov 20 02:40 PM
LILLY ENDOWMENT INC10% OwnerNov 16Sale113.74200,00022,747,000118,600,804Nov 19 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 13Sale113.412,460278,979118,800,804Nov 14 10:44 AM
LILLY ENDOWMENT INC10% OwnerNov 12Sale113.48202,54022,984,877118,803,264Nov 13 10:51 AM
LILLY ELI & CO10% OwnerNov 06Sale14.00700,0009,800,0003,148,647Nov 08 11:34 AM
Norton JohnaSenior VP, Global QualityNov 03Option Exercise0.003,133019,225Nov 06 01:25 PM
LILLY ENDOWMENT INC10% OwnerOct 17Sale113.25174,69619,783,623119,005,804Oct 18 02:26 PM
LILLY ENDOWMENT INC10% OwnerOct 09Sale115.9110,6721,237,013119,180,500Oct 10 01:17 PM
LILLY ENDOWMENT INC10% OwnerOct 08Sale115.9114,6321,696,039119,191,172Oct 09 01:14 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale112.67116,03813,073,950119,205,804Oct 05 02:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lOct 04Sale114.647,000802,48045,224Oct 05 02:08 PM
LILLY ENDOWMENT INC10% OwnerOct 03Sale109.0178,9628,607,253119,321,842Oct 04 02:29 PM
LILLY ENDOWMENT INC10% OwnerSep 28Sale107.31107,55311,541,082119,400,804Oct 01 11:53 AM
LILLY ENDOWMENT INC10% OwnerSep 27Sale107.0092,4479,891,644119,508,357Sep 28 10:36 AM
LILLY ENDOWMENT INC10% OwnerSep 26Sale106.63134,41014,332,373119,600,804Sep 27 12:26 PM
LILLY ENDOWMENT INC10% OwnerSep 25Sale106.4155,5905,915,165119,735,214Sep 26 01:49 PM
LILLY ELI & CO10% OwnerSep 24Sale16.362,02733,1623,848,647Sep 26 02:50 PM
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM